Dr. Jeffrey Kopin: What you should know about the Johnson & Johnson vaccine and a possible link to Guillain–Barré syndrome

Health

TIJUANA, MEXICO – JUNE 17: A health worker prepares a dose of the vaccine against COVID-19 at the mass vaccination center of the Universidad de Baja California on June 17, 2021 in Tijuana, Mexico. After the visit of Vice president Harris to Mexico, US sent a donation of 1.35 million doses of Johnson and Johnson vaccine. Vaccines will be administrated to anyone over 18 in 39 towns from the Mexican side of the border with United States. The aim of the project is to boost vaccination rates to level of the American cities across the border. (Photo by Francisco Vega/Getty Images)

Dr. Jeffrey Kopin, chief medical officer for Northwestern Medicine Lake Forest Hospital, joins guest host Lisa Dent to talk about what we know about the J&J vaccine and its possible link to a rare neurological disorder, why the vaccine is safe if you are trying to get pregnant, if the flu vaccine could provide protection against COVID or a variant, if the vaccine will need to be modified, and when we should expect a formal permanent approval of the vaccines from the FDA.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

COVID-19 risk as determined by nonprofit Covid Act Now.

Coronavirus Resources from the CDC

Coronavirus by State

COVID-19 Testing Vs. Confirmed Cases by State

Interactive: Coronavirus Timeline

Anna Davlantes
Weekdays 1-4pm AnnaDavlantes

Anna Davlantes is a Chicago native, a seven-time Emmy Award-winning journalist who has broken major stories, passionately told small stories and exposed corruption that has prompted major investigations and reform. (Click for more.)

Popular

More Home Page Top Stories